A Study Comparing the Addition of Structured Psychosocial Care versus Standard of Care to the Treatment of Patients with Inflammatory Bowel Disease

Overview

About this study

The purpose of the study is to compare the addition of structured psychosocial care versus standard medical care alone for the treatment of adult patients who have inflammatory bowel disease

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Written informed consent must be obtained and documented
  • Males or females
  • Between ages of 18 and 75 years
  • Documented diagnosis of CD or UC
  • Hospital Anxiety and Depression Score (HADS) of 10 – 20
  • Ability to participate fully in all aspects of clinical trial

Exclusion Criteria

  • Hospital Anxiety and Depression Score (HADS) of less than 10 or greater than
  • Serious underlying psychiatric disorder such as schizophrenia or bipolar disorder
  • History of illegal drug abuse (excluding marijuana) or alcohol abuse which in the opinion of the investigator may interfere with the subject’s ability to comply with the study procedures
  • Serious medical comorbidity which in the opinion of the investigator may interfere with the subject’s ability to comply with the study procedures

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Sunanda Kane, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions